# FDA 483 - David L. Scott, MD - November 18, 2022

Source: https://www.globalkeysolutions.net/records/483/david-l-scott-md/77caebbe-0b6b-41b1-939b-8d2f20568f7c

> FDA 483 for David L. Scott, MD on November 18, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: David L. Scott, MD
- Inspection Date: 2022-11-18
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - East I
- Summary: David L. Scott, MD, a clinical investigator in Laurelton, NY, was cited for significant deficiencies in conducting a clinical investigation and maintaining adequate records. The inspection revealed failures to properly implement corrective actions, report to the IRB promptly, adhere to data entry timelines, and accurately document adverse events and subject medications. These issues indicate a lack of adherence to the investigational plan and proper recordkeeping practices.

## Related Officers

- [Consumer Safety Officer/BIMO Investigator](https://www.globalkeysolutions.net/people/david-l-chon/227b9c21-14c4-442b-bdc3-ad167567fd92)

Company: https://www.globalkeysolutions.net/companies/david-l-scott-md/82dac8e8-1aec-4691-9c01-0b30f1c6b2f2

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-east-i/a807f00e-d780-40b8-b233-1eb92ece8961